publication . Article . 2012

Detection of Shiga toxin-producing Escherichia coli by sandwich enzyme-linked immunosorbent assay using chicken egg yolk IgY antibodies

Parma, Y. R.; Chacana, P. A.; Lucchesi, P. M.; Rogé, A.; Granobles Velandia, C. V.; Alejandra Krüger; Parma, A. E.; Fernández-Miyakawa, M. E.;
Open Access English
  • Published: 01 Jun 2012 Journal: Frontiers in Cellular and Infection Microbiology (issn: 2235-2988, Copyright policy)
  • Publisher: Frontiers Media S.A.
Enterohemorrhagic Escherichia coli (EHEC), a subset of Shiga toxin producing E. coli (STEC) is associated with a spectrum of diseases that includes diarrhea, hemorrhagic colitis and a life-threatening hemolytic uremic syndrome (HUS). Regardless of serotype, Shiga toxins (Stx1 and/or Stx2) are uniformly expressed by all EHEC, and so exploitable targets for laboratory diagnosis of these pathogens. In this study, a sandwich ELISA for determination of Shiga toxin (Stx) was developed using anti-Stx2 B subunit antibodies and its performance was compared with that of the Vero cell assay and a commercial immunoassay kit. Chicken IgY was used as capture antibody and a HR...
free text keywords: Egg Yolk, Escherichia coli, Shiga Toxin, STEC, ELISA, IgY, Microbiology, QR1-502, Original Research Article, chicken, Immunology, Microbiology (medical), Infectious Diseases, medicine.disease_cause, medicine, Vero cell, Antibody, biology.protein, biology, Virology, Serotype, STX2, Immunoassay, medicine.diagnostic_test, Recombinant DNA, law.invention, law
40 references, page 1 of 3

Ake J. A.Jelacic S.Ciol M. A. (2005). Relative nephroprotection during Escherichia coli O157:H7 infections: association with intravenous volume expansion. Pediatrics 115, 673–680 10.1542/peds.2004-2236 15741371 [OpenAIRE] [PubMed] [DOI]

Ambrosius H.Hadge D. (1987). Chicken immunoglobulins. Vet. Immunol. Immunopathol. 17, 57–67 10.1016/0165-2427(87)90127-9 3501633 [OpenAIRE] [PubMed] [DOI]

Azim T.Ronan A.Khan W. A.Salam M. A.Albert M. J.Bennish M. L. (1997). “Features of Shigella-associated hemolytic uremic syndrome (HUS) in children, abstr. V187/I,” in Third International Symposium and Workshop on Shiga Toxin (Verotoxin)-Producing Escherichia coli Infections (Melville, NY: Lois Joy Galler Foundation for Hemolytic Uremic Syndrome Inc.), 22

Ball H. J.Finlay D.Zafar A.Wilson T. (1996). The detection of verocytotoxins in bacterial cultures from human diarrhoeal samples with monoclonal antibody-based ELISAs. J. Med. Microbiol. 44, 273–276 8606355 [OpenAIRE] [PubMed]

Bettelheim K. A. (1998). Reliability of CHROMagar O157 for the detection of enterohaemorrhagic Escherichia coli (EHEC) O157 but not EHEC belonging to other serogroups. J. Appl. Microbiol. 85, 425–428 10.1046/j.1365-2672.1998.853469.x 9750272 [OpenAIRE] [PubMed] [DOI]

Bettelheim K. A.Beutin L. (2003). Rapid laboratory identification and characterization of verocytotoxigenic (Shiga toxin producing) Escherichia coli (VTEC/STEC). J. Appl. Microbiol. 95, 205–217 10.1046/j.1365-2672.2003.02031.x 12859750 [OpenAIRE] [PubMed] [DOI]

Beutin L.Gleier K.Kontny I.Echeverria P.Scheutz F. (1997). Origin and characteristics of enteroinvasive strains of Escherichia coli (EIEC) isolated in Germany. Epidemiol. Infect. 118, 199–205 9207729 [OpenAIRE] [PubMed]

Beutin L.Steinrück H.Krause G.Steege K.Haby S.Hultsch G.Appel B. (2007). Comparative evaluation of the Ridascreen® Verotoxin enzyme immunoassay for detection of Shiga-toxin producing strains of Escherichia coli (STEC) from food and other sources. J. Appl. Microbiol. 102, 630–639 10.1111/j.1365-2672.2006.03139.x 17309611 [OpenAIRE] [PubMed] [DOI]

Beutin L.Zimmermann S.Gleier K. (1996). Pseudomonas aeruginosa can cause false-positive identification of verotoxin (Shiga-like toxin) production by a commercial enzyme immune assay system for the detection of Shiga-like toxins (SLTs). Infection 24, 267–268 8811370 [PubMed]

Bhimma R.Rollins N.Coovadia H. M.Adhakiri M. (1997). “Hemolytic uremic syndrome following a Shigella dysenteriae type 1 outbreak in South Africa, abstr. V208/I,” in Third International Symposium and Workshop on Shiga Toxin (Verotoxin)-Producing Escherichia coli Infections (Melville, NY: Lois Joy Galler Foundation for Hemolytic Uremic Syndrome Inc.), 24

Brooks J. T.Sowers E. G.Wells J. G.Greene K. D.Griffin P. M.Hoekstra R. M.Strockbine N. A. (2005). Non-O157 Shiga toxin-producing Escherichia coli infections in the United States 1983–2002. J. Infect. Dis. 192, 1422–1429 10.1086/466536 16170761 [OpenAIRE] [PubMed] [DOI]

CDC. (2009). Recommendations for diagnosis of Shiga Toxin–Producing Escherichia coli infections by clinical Laboratories. MMWR Recomm. Rep. 58, 1–14 19834454 [PubMed]

Exeni R. (2001). Síndrome urémico hemolítico. Arch. Latin. Nefr. Ped. 1, 35–56

Friedrich A. W.Bielaszewska M.Zhang W.Pulz M.Kuczius T.Ammon A.Karch H. (2002). Escherichia coli harboring Shiga toxin 2 gene variants: frequently and association with clinical symptoms. J. Infect. Dis. 185, 74–84 10.1086/338115 11756984 [OpenAIRE] [PubMed] [DOI]

Gentry M. K.Dalrymple J. M. (1980). Quantitative microtiter cytotoxicity assay for Shigella toxin. J. Clin. Microbiol. 12, 361–366 7012172 [OpenAIRE] [PubMed]

40 references, page 1 of 3
Powered by OpenAIRE Research Graph
Any information missing or wrong?Report an Issue